{"slideshow_credits": null, "snippet": "Hundreds or even thousands of lives are at risk after a major manufacturer suspended production of methotrexate, a treatment for childhood leukemia.", "abstract": "Methotrexate, crucial medicine to treat childhood leukemia, is in such short supply that hospitals across the country may exhaust their stores within two weeks; supplies of drug have dwindled since Ben Venue Laboratories, one of the nation's largest suppliers, voluntarily suspended operations at its plant.", "section_name": "Health", "print_page": "15", "document_type": "article", "byline": {"person": [{"firstname": "Gardiner", "role": "reported", "lastname": "HARRIS", "rank": 1, "organization": ""}], "original": "By GARDINER HARRIS", "contributor": ""}, "web_url": "http://www.nytimes.com/2012/02/11/health/policy/supply-of-methotrexate-a-cancer-drug-may-run-out-soon.html", "lead_paragraph": "Hundreds or even thousands of lives are at risk after a major manufacturer suspended production of methotrexate, a treatment for childhood leukemia.", "headline": {"seo": "Supply of Methotrexate, a Cancer Drug, May Run Out Soon", "main": "Supply of a Cancer Drug May Run Out Within Weeks", "print_headline": "Supply of a Cancer Drug May Run Out in Weeks"}, "_id": "53f37a2638f0d857ea2d0238", "word_count": "602", "multimedia": [{"height": 75, "url": "images/2012/02/11/us/DRUG/DRUG-thumbStandard.jpg", "legacy": {"thumbnail": "images/2012/02/11/us/DRUG/DRUG-thumbStandard.jpg", "thumbnailwidth": "75", "thumbnailheight": "75"}, "subtype": "thumbnail", "width": 75, "type": "image"}], "pub_date": "2012-02-11T00:00:00Z", "source": "The New York Times", "news_desk": "National", "keywords": [{"value": "Methotrexate (Drug)", "name": "subject", "is_major": "Y", "rank": "1"}, {"value": "Shortages", "name": "subject", "is_major": "Y", "rank": "2"}, {"value": "Food and Drug Administration", "name": "organizations", "is_major": "N", "rank": "3"}, {"value": "Leukemia", "name": "subject", "is_major": "Y", "rank": "4"}, {"value": "Rheumatoid Arthritis", "name": "subject", "is_major": "N", "rank": "5"}, {"value": "Drugs (Pharmaceuticals)", "name": "subject", "is_major": "Y", "rank": "6"}], "blog": [], "subsection_name": "Money & Policy", "type_of_material": "News"}